Yes, Apogee Therapeutics is a fully legitimate, publicly traded clinical-stage biotechnology corporation listed on the Nasdaq Global Select Market under the ticker symbol APGE. The company maintains legitimate corporate headquarters, active research laboratories, and advanced therapeutic pipelines targeting major immunological conditions.